Schedule 13G ownership disclosure

LAVA THERAPEUTICS NV

Common shares, par value $0.14 per share · CUSIP: N51517105

Event date: 2025-02-26

Filing-level shares
1,958,110
Percent of class
7.4%
  • BML Investment Partners, L.P.

    Shares: 1,958,110 · Class: 7.4%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001373604-25-000043
Form type
SCHEDULE 13G
Filer
BML Investment Partners, L.P.
CIK
CIK 1373604
Filed
Mar 03, 2025
Reporting period
Feb 26, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub